Pro-ficiency
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 2.5m | 3.1m | 3.4m | 3.9m | 6.8m |
% growth | - | 24 % | 10 % | 15 % | 73 % |
Date | Investors | Amount | Round |
---|---|---|---|
$3.0m | Growth Equity VC | ||
* | N/A | $3.2m | Late VC |
* | N/A | Acquisition | |
Total Funding | €5.6m |
Related Content
Recent News about Pro-ficiency
EditPro-ficiency specializes in simulation-based training for clinical trials, offering a unique blend of technology and expertise to deliver comprehensive medical education and strategic meetings. The company operates in the life sciences and medical communication sectors, providing customized solutions that adhere to stringent regulatory standards. Pro-ficiency's proprietary simulation technology translates complex clinical trial protocols into engaging, risk-free scenarios, enabling investigators to deeply internalize critical content. This approach generates behavior-based analytics that predict risks before they occur, enhancing decision-making and operational efficiency. The company's business model revolves around offering tailored training modules and consulting services to pharmaceutical companies, clinical research organizations, and healthcare providers. Revenue is generated through the sale of these specialized training programs and consulting engagements.
Keywords: clinical trials, simulation training, medical education, risk analytics, life sciences, regulatory compliance, pharmaceutical, healthcare, technology-enabled, customized solutions.